| UniProt ID | JMY_HUMAN | |
|---|---|---|
| UniProt AC | Q8N9B5 | |
| Protein Name | Junction-mediating and -regulatory protein | |
| Gene Name | JMY | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 988 | |
| Subcellular Localization | Nucleus. Cytoplasm, cytoskeleton . Localizes to the nucleus in most cell types. Accumulates in nucleus under DNA damage conditions, increasing p53/TP53 transcription response and reducing its influence on cell motility (By similarity). In primary neu | |
| Protein Description | Acts both as a nuclear p53/TP53-cofactor and a cytoplasmic regulator of actin dynamics depending on conditions. In nucleus, acts as a cofactor that increases p53/TP53 response via its interaction with p300/EP300. Increases p53/TP53-dependent transcription and apoptosis, suggesting an important role in p53/TP53 stress response such as DNA damage. In cytoplasm, acts as a nucleation-promoting factor for both branched and unbranched actin filaments. Activates the Arp2/3 complex to induce branched actin filament networks. Also catalyzes actin polymerization in the absence of Arp2/3, creating unbranched filaments. Contributes to cell motility by controlling actin dynamics. May promote the rapid formation of a branched actin network by first nucleating new mother filaments and then activating Arp2/3 to branch off these filaments. The p53/TP53-cofactor and actin activator activities are regulated via its subcellular location (By similarity).. | |
| Protein Sequence | MSFALEETLESDWVAVRPHVFDEREKHKFVFIVAWNEIEGKFAITCHNRTAQRQRSGSREQAGARGGAEAGGAASDGSRGPGSPAGRGRPEATASATLVRSPGPRRSSAWAEGGSPRSTRSLLGDPRLRSPGSKGAESRLRSPVRAKPIPGQKTSEADDAAGAAAAAARPAPREAQVSSVRIVSASGTVSEEIEVLEMVKEDEAPLALSDAEQPPPATELESPAEECSWAGLFSFQDLRAVHQQLCSVNSQLEPCLPVFPEEPSGMWTVLFGGAPEMTEQEIDTLCYQLQVYLGHGLDTCGWKILSQVLFTETDDPEEYYESLSELRQKGYEEVLQRARKRIQELLDKHKNTESMVELLDLYQMEDEAYSSLAEATTELYQYLLQPFRDMRELAMLRRQQIKISMENDYLGPRRIESLQKEDADWQRKAHMAVLSIQDLTVKYFEITAKAQKAVYDRMRADQKKFGKASWAAAAERMEKLQYAVSKETLQMMRAKEICLEQRKHALKEEMQSLRGGTEAIARLDQLEADYYDLQLQLYEVQFEILKCEELLLTAQLESIKRLISEKRDEVVYYDTYESMEAMLEKEEMAASAYLQREELQKLQQKARQLEARRGRVSAKKSYLRNKKEICIAKHNEKIQQRTRIEDEYRTHHTVQLKREKLHDEEERKSAWVSQERQRTLDRLRTFKQRYPGQVILKSTRLRLAHARRKGAASPVLQEDHCDSLPSVLQVEEKTEEVGEGRVKRGPSQTTEPQSLVQLEDTSLTQLEATSLPLSGVTSELPPTISLPLLNNNLEPCSVTINPLPSPLPPTPPPPPPPPPPPPPPPLPVAKDSGPETLEKDLPRKEGNEKRIPKSASAPSAHLFDSSQLVSARKKLRKTAEGLQRRRVSSPMDEVLASLKRGSFHLKKVEQRTLPPFPDEDDSNNILAQIRKGVKLKKVQKDVLRESFTLLPDTDPLTRSIHEALRRIKEASPESEDEEEALPCTDWEN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSFALEETL ------CCCCCHHHH | 21.16 | 28348404 | |
| 56 | Phosphorylation | RTAQRQRSGSREQAG HHHHCHHCCCHHHHH | 32.55 | - | |
| 58 | Phosphorylation | AQRQRSGSREQAGAR HHCHHCCCHHHHHHC | 33.61 | - | |
| 65 | Methylation | SREQAGARGGAEAGG CHHHHHHCCCCCCCC | 43.06 | 115387713 | |
| 83 | Phosphorylation | DGSRGPGSPAGRGRP CCCCCCCCCCCCCCC | 18.08 | 23532336 | |
| 87 | Methylation | GPGSPAGRGRPEATA CCCCCCCCCCCCCCC | 39.80 | 115480745 | |
| 89 | Methylation | GSPAGRGRPEATASA CCCCCCCCCCCCCEE | 25.23 | 115480751 | |
| 93 | Phosphorylation | GRGRPEATASATLVR CCCCCCCCCEEEEEE | 21.34 | 30576142 | |
| 95 | Phosphorylation | GRPEATASATLVRSP CCCCCCCEEEEEECC | 19.89 | 30576142 | |
| 101 | Phosphorylation | ASATLVRSPGPRRSS CEEEEEECCCCCCCC | 27.08 | 26074081 | |
| 107 | Phosphorylation | RSPGPRRSSAWAEGG ECCCCCCCCCCCCCC | 26.20 | 23403867 | |
| 108 | Phosphorylation | SPGPRRSSAWAEGGS CCCCCCCCCCCCCCC | 26.47 | 23403867 | |
| 115 | Phosphorylation | SAWAEGGSPRSTRSL CCCCCCCCCCCHHHH | 28.17 | 23401153 | |
| 118 | Phosphorylation | AEGGSPRSTRSLLGD CCCCCCCCHHHHHCC | 31.40 | 26074081 | |
| 119 | Phosphorylation | EGGSPRSTRSLLGDP CCCCCCCHHHHHCCC | 26.09 | 26074081 | |
| 121 | Phosphorylation | GSPRSTRSLLGDPRL CCCCCHHHHHCCCCC | 28.21 | 23401153 | |
| 130 | Phosphorylation | LGDPRLRSPGSKGAE HCCCCCCCCCCCCHH | 37.90 | 23403867 | |
| 133 | Phosphorylation | PRLRSPGSKGAESRL CCCCCCCCCCHHHHC | 31.16 | 23403867 | |
| 142 | Phosphorylation | GAESRLRSPVRAKPI CHHHHCCCCCCCCCC | 32.13 | 25159151 | |
| 155 | Phosphorylation | PIPGQKTSEADDAAG CCCCCCCCCHHHHHH | 37.51 | 28555341 | |
| 319 | Phosphorylation | ETDDPEEYYESLSEL CCCCHHHHHHHHHHH | 15.75 | 28796482 | |
| 320 | Phosphorylation | TDDPEEYYESLSELR CCCHHHHHHHHHHHH | 11.43 | 28796482 | |
| 322 | Phosphorylation | DPEEYYESLSELRQK CHHHHHHHHHHHHHC | 22.52 | 28796482 | |
| 324 | Phosphorylation | EEYYESLSELRQKGY HHHHHHHHHHHHCCH | 43.81 | 28796482 | |
| 329 | Ubiquitination | SLSELRQKGYEEVLQ HHHHHHHCCHHHHHH | 57.96 | 24816145 | |
| 348 | Ubiquitination | RIQELLDKHKNTESM HHHHHHHHCCCCHHH | 57.35 | 29967540 | |
| 409 | Phosphorylation | KISMENDYLGPRRIE HHHCCCCCCCHHHHH | 25.74 | 25159151 | |
| 420 | Ubiquitination | RRIESLQKEDADWQR HHHHHHHHCCCHHHH | 63.96 | 29967540 | |
| 427 | Methylation | KEDADWQRKAHMAVL HCCCHHHHHHHHHHH | 33.60 | 24377421 | |
| 427 | Dimethylation | KEDADWQRKAHMAVL HCCCHHHHHHHHHHH | 33.60 | - | |
| 467 | Ubiquitination | ADQKKFGKASWAAAA HHHHHHCHHHHHHHH | 42.24 | - | |
| 479 | Ubiquitination | AAAERMEKLQYAVSK HHHHHHHHHHHHHCH | 31.39 | 29967540 | |
| 495 | Ubiquitination | TLQMMRAKEICLEQR HHHHHHHHHHHHHHH | 36.93 | 29967540 | |
| 530 | Phosphorylation | LDQLEADYYDLQLQL HHHHHCHHHHHHHHH | 13.11 | 24043423 | |
| 531 | Phosphorylation | DQLEADYYDLQLQLY HHHHCHHHHHHHHHH | 15.66 | 24043423 | |
| 538 | Phosphorylation | YDLQLQLYEVQFEIL HHHHHHHHHHHHHHH | 10.90 | 24043423 | |
| 560 | Ubiquitination | TAQLESIKRLISEKR HHHHHHHHHHHHCCC | 50.89 | 29967540 | |
| 564 | Phosphorylation | ESIKRLISEKRDEVV HHHHHHHHCCCCCEE | 41.48 | 24719451 | |
| 572 | Phosphorylation | EKRDEVVYYDTYESM CCCCCEEEEECHHHH | 10.78 | - | |
| 576 | Phosphorylation | EVVYYDTYESMEAML CEEEEECHHHHHHHH | 11.78 | - | |
| 601 | Ubiquitination | LQREELQKLQQKARQ HCHHHHHHHHHHHHH | 61.97 | 29967540 | |
| 648 | Phosphorylation | RTRIEDEYRTHHTVQ HHHCHHHHHHHHHHH | 32.88 | 27642862 | |
| 657 | Ubiquitination | THHTVQLKREKLHDE HHHHHHHHHHHCCCH | 41.23 | 29967540 | |
| 668 | Ubiquitination | LHDEEERKSAWVSQE CCCHHHHHHHHHHHH | 48.05 | 29967540 | |
| 713 | Phosphorylation | ARRKGAASPVLQEDH HHHCCCCCCCCCCHH | 18.27 | 29255136 | |
| 723 | Phosphorylation | LQEDHCDSLPSVLQV CCCHHCCCCCCEEEE | 47.80 | 22167270 | |
| 726 | Phosphorylation | DHCDSLPSVLQVEEK HHCCCCCCEEEEECC | 40.53 | 25850435 | |
| 734 | Phosphorylation | VLQVEEKTEEVGEGR EEEEECCCCCCCCCC | 40.43 | 23312004 | |
| 832 | O-linked_Glycosylation | PLPVAKDSGPETLEK CCCCCCCCCCCCHHH | 56.38 | 30379171 | |
| 854 | Phosphorylation | NEKRIPKSASAPSAH CCCCCCCCCCCCCCC | 23.31 | 28857561 | |
| 856 | Phosphorylation | KRIPKSASAPSAHLF CCCCCCCCCCCCCCC | 48.05 | 28857561 | |
| 859 | Phosphorylation | PKSASAPSAHLFDSS CCCCCCCCCCCCCHH | 28.21 | 28464451 | |
| 865 | Phosphorylation | PSAHLFDSSQLVSAR CCCCCCCHHHHHHHH | 16.79 | 23186163 | |
| 866 | Phosphorylation | SAHLFDSSQLVSARK CCCCCCHHHHHHHHH | 29.40 | 23312004 | |
| 870 | Phosphorylation | FDSSQLVSARKKLRK CCHHHHHHHHHHHHH | 30.83 | 25159151 | |
| 888 | Phosphorylation | GLQRRRVSSPMDEVL HHHHHHCCCCHHHHH | 27.23 | 25159151 | |
| 889 | Phosphorylation | LQRRRVSSPMDEVLA HHHHHCCCCHHHHHH | 22.76 | 23927012 | |
| 897 | Phosphorylation | PMDEVLASLKRGSFH CHHHHHHHHHHCCEE | 30.20 | 22912867 | |
| 902 | Phosphorylation | LASLKRGSFHLKKVE HHHHHHCCEEEEEEH | 17.33 | 26546556 | |
| 946 | Phosphorylation | QKDVLRESFTLLPDT HHHHHHHHHCCCCCC | 19.66 | 25159151 | |
| 948 | Phosphorylation | DVLRESFTLLPDTDP HHHHHHHCCCCCCCH | 36.34 | 27251275 | |
| 957 | Phosphorylation | LPDTDPLTRSIHEAL CCCCCHHHHHHHHHH | 27.97 | - | |
| 959 | Phosphorylation | DTDPLTRSIHEALRR CCCHHHHHHHHHHHH | 24.06 | - | |
| 971 | Phosphorylation | LRRIKEASPESEDEE HHHHHHHCCCCCCHH | 30.23 | 28102081 | |
| 974 | Phosphorylation | IKEASPESEDEEEAL HHHHCCCCCCHHHHC | 54.45 | 22617229 | |
| 984 | Phosphorylation | EEEALPCTDWEN--- HHHHCCCCCCCC--- | 42.05 | 22210691 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of JMY_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of JMY_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of JMY_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115 AND SER-974, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-974, AND MASSSPECTROMETRY. | |